Investment for health and wellbeing

Welcome to join our Q4 2024 results webcast on 4 March 2025 at 10 a.m. EET

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Financial Statements Release 2024

Oriola will publish its Financial Statements Release 2024 on Tuesday 4 March 2025 at around 8.30 a.m. Welcome to join our results presentation as a live webcast at 10 a.m. on the same day.

Join the webcast See the invitation

Annual Report 2023

Our Annual Report consists of the following sections: Business review, Sustainability report, Corporate governance statement, Remuneration report, Report of the Board of Directors and Financial statements.

Find out more

Shortcut to investor tools

Key figures Share information Shareholders

Latest stock exchange releases

07.02.2025 | Stock exchange releases

Oriola Corporation’s shareholder’s demand for including combination of share classes and directed issuance of shares without payment in the agenda of the Annual General Meeting
23.01.2025 | Stock exchange releases

Proposals of the Shareholders’ Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2025 Annual General Meeting
19.12.2024 | Stock exchange releases

Oriola to record an impairment of approximately EUR 16 million related to its joint venture Kronans Apotek
See all stock exchange releases from our newsroom Subscribe to releases

Looking for financial reports or other financial information?

Reports and presentations Financial information Investor calendar Investor contacts